查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1701356

体外大肠直肠癌筛检测试市场规模、份额和趋势分析报告：按测试、最终用途、地区、

In-vitro Colorectal Cancer Screening Tests Market Size, Share & Trends Analysis Report By Test (Fecal Occult Blood Tests, Biomarker Tests), By End-use (Hospitals & Clinics, Diagnostic Laboratories),By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 129 Pages | 商品交期: 2-10个工作天内

价格

体外大肠直肠癌筛检测试市场成长与趋势：

根据Grand View Research, Inc.的最新报告，全球体外大肠癌筛检市场规模预计到2030年将达到17亿美元，2025年至2030年的复合年增长率为4.7%。

为了应对日益增多的结肠和直肠恶性肿瘤患者，新的筛检模型的出现是影响市场成长的主要因素。肿瘤M2-PK粪便检验和甲基化基因检测等新开发的基因和生物标记检测的出现有望提高肿瘤诊断模型的采用率。

大肠直肠恶性肿瘤发生率的不断上升是该领域成长的主要驱动力。例如，根据日本国家癌症中心2022年6月发布的数据，预计2022年日本将新增约101.9万例癌症病例，其中结直肠癌（CRC）预计将占15.82万例新病例。同样，根据澳洲癌症协会 2022 年 8 月更新的数据，预计 2022 年澳洲将诊断出 15,713 例新的 CRC 病例，其中男性诊断出 8,300 例，女性诊断出 7,413 例。因此，预计大肠直肠恶性肿瘤盛行率的上升将推动对大肠镜检查设备的需求。

政府当局为促进筛检而实施的各种倡议正在对体外 CRC 筛检的需求产生积极影响。例如，Cancer.org 报告称，加州卫生系统在 2020 年 4 月至 5 月期间继续提供 FIT套件（粪便免疫化学检查），儘管爆发了 COVID-19 疫情，但 FIT 的回应率仍然很高。此外，欧洲癌症界已调动资源来评估、解决和减轻COVID-19对筛检的负面影响。这些努力有助于维持对体外筛检测试的需求。

此外，预计市场成长将受到主要市场参与企业增加产品推出的推动。这些产品的发布旨在提供技术先进和创新的产品。例如，Pillar Biosciences, Inc. 于 2021 年 7 月获得 FDA核准使用 ONCO/Reveal Dx 肺癌和结肠癌检测 (O/RDx-LCCA) 来检测 CRC。

体外大肠直肠癌筛检测试市场亮点：

  • 大便潜血试验部分将主导体外大肠直肠癌筛检检测产业，2024 年的最大收益占有率将达到 82.3%。生物标记测试领域预计将成为成长最快的领域，2025 年至 2030 年的复合年增长率为 5.8%。
  • 诊断实验室部门凭藉其先进的技术、高精度和全面的测试能力，预计将在 2024 年占据最大的收益占有率。由于对早期诊断和非侵入性检测选项的需求不断增长，医院和诊所部门预计在预测期内将以显着的速度增长。
  • 2024 年，北美体外大肠直肠癌筛检测试市场占据全球市场主导地位，收益占有率最大，为 39.5%。 2024 年，美国体外大肠直肠癌筛检测试市场占有最大份额。
  • 2025 年至 2030 年期间，亚太地区体外结直肠癌筛检测试市场将以 5.2% 的最快复合年增长率扩张。

目录

第一章调查方法与范围

第二章执行摘要

3. 体外大肠直肠癌筛检测试市场变数、趋势和范围

  • 市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析-波特五力分析
    • PESTLE分析

第四章体外大肠直肠癌筛检测试市场：测试业务分析

  • 2024年和2030年的测试市场占有率
  • 检查细分仪表板
  • 市场规模、预测与趋势分析（按测试，2018-2030 年）
  • 大便潜血试验
  • 生物标记检测
  • 其他方法

5. 体外大肠直肠癌筛检测试市场：依最终用途分類的业务分析

  • 2024 年及 2030 年最终用途市场占有率
  • 最终用途细分仪表板
  • 2018 年至 2030 年市场规模、预测、趋势分析（按应用）
  • 医院和诊所
  • 诊断实验室
  • 其他的

6. 体外大肠直肠癌筛检市场：区域估计与趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 市场规模、预测趋势分析，2018 年至 2030 年：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 西班牙
    • 法国
    • 义大利
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章竞争格局

  • 参与者概述
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/列表
    • Abbott
    • Epigenomics AG
    • Beckman Coulter, Inc.
    • Eiken Chemical Co., Ltd.
    • Sysmex Corporation
    • Siemens Healthineers AG
    • Quest Diagnostics Incorporated
    • Oncocyte Corporation
    • Merck KGaA
    • Immunostics Inc.
    • Kyowa Kirin Co., Ltd.
    • Randox Laboratories Ltd.
    • R-Biopharm AG
Product Code: 978-1-68038-438-3

In-vitro Colorectal Cancer Screening Tests Market Growth & Trends:

The global in-vitro colorectal cancer screening tests market size is expected to reach USD 1.7 billion by 2030, registering a CAGR of 4.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising number of novel screening models to combat the increasing incidences of colon and rectal malignancy cases is the major factor influencing the market growth. The emergence of newly developed genetic and biomarker tests such as tumor M2-PK stool tests and methylated gene testing is anticipated to drive the adoption rate of tumor diagnostic models.

The increasing incidence of colorectal malignancy is a significant driver for the growth of the segment. For example, according to data released by the National Cancer Center Japan in June 2022, it was projected that there would be approximately 1,019,000 new cases of cancer in Japan in 2022, with Colorectal Cancer (CRC) accounting for an estimated 158,200 new cases. Similarly, data updated by Cancer Australia in August 2022 indicated that 15,713 new cases of CRC were expected to be diagnosed in Australia in 2022, with 8,300 cases among males and 7,413 cases among females. As a result, the increasing prevalence of colorectal malignance is anticipated to drive the demand for colonoscopy devices.

The implementation of various initiatives by public organizations to promote screening has positively impacted the demand for in-vitro CRC screenings. For instance, according to reports from Cancer.org, healthcare systems in California continued to provide FIT kits (fecal immunochemical tests) during the months of April and May 2020, and the response rates for FIT remained high despite the onset of the COVID-19 pandemic. Additionally, the European Cancer community has mobilized its resources to evaluate, address, and mitigate the adverse effects of COVID-19 on screening. These efforts have contributed to the sustained demand for in-vitro screening tests.

Furthermore, market growth is expected to be driven by the increasing number of product launches by major market players. These product launches are aimed at providing access to technologically advanced and innovative products. For instance, Pillar Biosciences, Inc. received FDA approval for the ONCO/Reveal Dx Lung & Colon Cancer Assay (O/RDx-LCCA) in July 2021 for the detection of CRC.

In-vitro Colorectal Cancer Screening Tests Market Report Highlights:

  • The fecal occult blood tests segment dominated the in-vitro colorectal cancer screening tests industry, with the largest revenue share of 82.3% in 2024. The biomarker tests segment is anticipated to emerge as the fastest-growing segment and grow at a CAGR of 5.8% from 2025 to 2030.
  • The diagnostic laboratories segment held the largest revenue share in 2024, attributed to their advanced technology, high accuracy, and comprehensive testing capabilities. The hospitals and clinics segment is expected to grow at a significant pace during the forecast period, fueled by the increasing demand for early diagnosis and noninvasive testing options.
  • North America in-vitro colorectal cancer screening tests market dominated the global market with the largest revenue share of 39.5% in 2024. The U.S. in-vitro colorectal cancer screening tests market held the largest share in 2024.
  • Asia Pacific in-vitro colorectal cancer screening tests market is set to expand at the fastest CAGR of 5.2% from 2025 to 2030.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Test
    • 1.2.2. End Use
    • 1.2.3. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. In-vitro Colorectal Cancer Screening Tests Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. In-vitro Colorectal Cancer Screening Tests Market: Test Business Analysis

  • 4.1. Test Market Share, 2024 & 2030
  • 4.2. Test Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, By Test, 2018 to 2030 (USD Million)
  • 4.4. Fecal Occult Blood Tests
    • 4.4.1. Fecal Occult Blood Tests Market, 2018 - 2030 (USD Million)
    • 4.4.2. Guaiac FOB Stool Test
      • 4.4.2.1. Guaiac FOB Stool Test Market, 2018 - 2030 (USD Million)
    • 4.4.3. Immuno-FOB Agglutination Test
      • 4.4.3.1. Immuno-FOB Agglutination Test Market, 2018 - 2030 (USD Million)
    • 4.4.4. Lateral Flow Immuno-FOB Test
      • 4.4.4.1. Lateral Flow Immuno-FOB Test Market, 2018 - 2030 (USD Million)
    • 4.4.5. Immuno-FOB ELISA Test
      • 4.4.5.1. Immuno-FOB ELISA Test Market, 2018 - 2030 (USD Million)
  • 4.5. Biomarker Tests
    • 4.5.1. Biomarker Tests Market, 2018 - 2030 (USD Million)
  • 4.6. Other Methods
    • 4.6.1. Other Methods Market, 2018 - 2030 (USD Million)

Chapter 5. In-vitro Colorectal Cancer Screening Tests Market: End Use Business Analysis

  • 5.1. End Use Market Share, 2024 & 2030
  • 5.2. End Use Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, By End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals and Clinics
    • 5.4.1. Hospitals and Clinics Market, 2018 - 2030 (USD Million)
  • 5.5. Diagnostic Laboratories
    • 5.5.1. Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. In-vitro Colorectal Cancer Screening Tests Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamic
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamic
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamic
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. U.K.
      • 6.5.2.1. Key Country Dynamic
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. U.K. In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamic
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. Spain
      • 6.5.4.1. Key Country Dynamic
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. Spain In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. France
      • 6.5.5.1. Key Country Dynamic
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. France In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Italy
      • 6.5.6.1. Key Country Dynamic
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Italy In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamic
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Denmark In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamic
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Sweden In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamic
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Norway In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamic
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamic
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamic
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamic
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamic
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamic
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamic
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamic
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Middle East and Africa
    • 6.8.1. Middle East and Africa In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamic
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamic
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamic
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamic
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Abbott
      • 7.5.1.1. Participant's Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Epigenomics AG
      • 7.5.2.1. Participant's Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Beckman Coulter, Inc.
      • 7.5.3.1. Participant's Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Eiken Chemical Co., Ltd.
      • 7.5.4.1. Participant's overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Sysmex Corporation
      • 7.5.5.1. Participant's Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Siemens Healthineers AG
      • 7.5.6.1. Participant's Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Quest Diagnostics Incorporated
      • 7.5.7.1. Participant's Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Oncocyte Corporation
      • 7.5.8.1. Participant's Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Merck KGaA
      • 7.5.9.1. Participant's Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Immunostics Inc.
      • 7.5.10.1. Participant's Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives
    • 7.5.11. Kyowa Kirin Co., Ltd.
      • 7.5.11.1. Participant's Overview
      • 7.5.11.2. Financial Performance
      • 7.5.11.3. Product Benchmarking
      • 7.5.11.4. Strategic Initiatives
    • 7.5.12. Randox Laboratories Ltd.
      • 7.5.12.1. Participant's Overview
      • 7.5.12.2. Financial Performance
      • 7.5.12.3. Product Benchmarking
      • 7.5.12.4. Strategic Initiatives
    • 7.5.13. R-Biopharm AG
      • 7.5.13.1. Participant's Overview
      • 7.5.13.2. Financial Performance
      • 7.5.13.3. Product Benchmarking
      • 7.5.13.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global In-vitro Colorectal Cancer Screening Tests Market, By Region, 2018 - 2030 (USD Million)
  • Table 4. Global In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 5. Global In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 6. North America In-vitro Colorectal Cancer Screening Tests Market, By Country, 2018 - 2030 (USD Million)
  • Table 7. North America In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 8. North America In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 9. U.S. In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 10. U.S. In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 11. Canada In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 12. Canada In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 13. Mexico In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 14. Mexico In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 15. Europe In-vitro Colorectal Cancer Screening Tests Market, By Country, 2018 - 2030 (USD Million)
  • Table 16. Europe In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 17. Europe In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 18. U.K. In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 19. U.K. In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 20. Germany In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 21. Germany In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 22. Spain In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 23. Spain In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 24. France In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 25. France In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 26. Italy In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 27. Italy In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 28. Denmark In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 29. Denmark In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 30. Sweden In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 31. Sweden In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 32. Norway In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 33. Norway In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific In-vitro Colorectal Cancer Screening Tests Market, By Country, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 36. Asia Pacific In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 37. Japan In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 38. Japan In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 39. China In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 40. China In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 41. India In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 42. India In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 43. South Korea In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 44. South Korea In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 45. Australia In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 46. Australia In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 47. Thailand In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 48. Thailand In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 49. Latin America In-vitro Colorectal Cancer Screening Tests Market, By Country, 2018 - 2030 (USD Million)
  • Table 50. Latin America In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 51. Latin America In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 52. Brazil In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 53. Brazil In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 54. Argentina In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 55. Argentina In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market, By Country, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 58. Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 59. South Africa In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 60. South Africa In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 63. UAE In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 64. UAE In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 65. Kuwait In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 66. Kuwait In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 In-vitro Colorectal Cancer Screening Tests Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Snapshot
  • Fig. 9 Test and End Use Outlook (USD Million)
  • Fig. 11 Competitive Landscape
  • Fig. 12 In-vitro Colorectal Cancer Screening Tests Market Dynamics
  • Fig. 13 In-vitro Colorectal Cancer Screening Tests Market: Porter's Five Forces analysis
  • Fig. 14 In-vitro Colorectal Cancer Screening Tests Market: PESTLE Analysis
  • Fig. 15 In-vitro Colorectal Cancer Screening Tests Market: Test Segment Dashboard
  • Fig. 16 In-vitro Colorectal Cancer Screening Tests Market: Test Market Share Analysis, 2024 & 2030
  • Fig. 17 Fecal Occult Blood Tests Market, 2018 - 2030 (USD Million)
  • Fig. 18 Biomarker Tests Market, 2018 - 2030 (USD Million)
  • Fig. 19 Other Methods Market, 2018 - 2030 (USD Million)
  • Fig. 20 In-vitro Colorectal Cancer Screening Tests Market: End Use Segment Dashboard
  • Fig. 21 In-vitro Colorectal Cancer Screening Tests Market: End Use Market Share Analysis, 2024 & 2030
  • Fig. 22 Hospitals and Clinics Market, 2018 - 2030 (USD Million)
  • Fig. 23 Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
  • Fig. 24 Others Market, 2018 - 2030 (USD Million)
  • Fig. 25 In-vitro Colorectal Cancer Screening Tests Market Revenue, By Region
  • Fig. 26 Regional Marketplace: Key Takeaways
  • Fig. 27 Regional Marketplace: Key Takeaways
  • Fig. 28 North America In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Country Dynamics
  • Fig. 30 U.S. In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 31 Canada Country Dynamics
  • Fig. 32 Canada In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 33 Mexico Country Dynamics
  • Fig. 34 Mexico In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 35 Europe In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 36 U.K. Country Dynamics
  • Fig. 37 U.K. In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 38 Germany Country Dynamics
  • Fig. 39 Germany In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 40 Spain Country Dynamics
  • Fig. 41 Spain In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 42 France Country Dynamics
  • Fig. 43 France In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy Country Dynamics
  • Fig. 45 Italy In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark Country Dynamics
  • Fig. 47 Denmark In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 48 Sweden Country Dynamics
  • Fig. 49 Sweden In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 50 Norway Country Dynamics
  • Fig. 51 Norway In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan Country Dynamics
  • Fig. 54 Japan In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 55 China Country Dynamics
  • Fig. 56 China In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 57 India Country Dynamics
  • Fig. 58 India In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 59 South Korea Country Dynamics
  • Fig. 60 South Korea In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 61 Australia Country Dynamics
  • Fig. 62 Australia In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand Country Dynamics
  • Fig. 64 Thailand In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 65 Latin America In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 66 Brazil Country Dynamics
  • Fig. 67 Brazil In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina Country Dynamics
  • Fig. 69 Argentina In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 70 Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 71 South Africa Country Dynamics
  • Fig. 72 South Africa In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 73 Saudi Arabia Country Dynamics
  • Fig. 74 Saudi Arabia In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 75 UAE Country Dynamics
  • Fig. 76 UAE In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 77 Kuwait Key Country Dynamics
  • Fig. 78 Kuwait In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 79 Company Categorization
  • Fig. 80 Company Market Position Analysis
  • Fig. 81 Strategic Framework